Date Filed | Type | Description |
08/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2020 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 4,240 shares
@ $1.209, valued at
$5.1k
|
|
03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/12/2019 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,175 shares
@ $6.056, valued at
$7.1k
|
|
05/14/2019 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 995 shares
@ $6.9898, valued at
$7k
|
|
03/14/2019 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,530 shares
@ $6.49, valued at
$9.9k
|
|
01/18/2019 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Granted 565,000 options to buy
@ $7.53, valued at
$4.3M
|
|
05/16/2018 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,725 shares
@ $5.85, valued at
$10.1k
|
|
03/15/2018 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,160 shares
@ $6.885, valued at
$8k
|
|
01/05/2018 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Granted 437,500 options to buy
@ $8.35, valued at
$3.7M
|
|
11/13/2017 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,000 shares
@ $7.1685, valued at
$7.2k
|
|
08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/12/2017 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 3,250 shares
@ $6.012, valued at
$19.5k
|
|
03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/20/2017 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/18/2016 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Exercised 20,000 options to buy
@ $1, valued at
$20k
|
|
06/07/2016 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 1,500 shares
@ $3.34, valued at
$5k
|
|
05/19/2016 |
4
| Cohen Yuval (CEO) has filed a Form 4 on Corbus Pharmaceuticals Holdings, Inc.
Txns:
| Bought 2,125 shares
@ $2.4, valued at
$5.1k
|
|